	US 11,744,841 B2
	Use of trezastilbenoside in manufacture of product for treating and/or preventing disease of respiratory system
Yidan Liu, Yunnan (CN); Xujuan Yang, Yunnan (CN); Xi Huang, Yunnan (CN); Qing Huang, Yunnan (CN); Shuixian Zhao, Yunnan (CN); Guoguang Liu, Yunnan (CN); and Jianhua Shang, Yunnan (CN)
Assigned to KPC PHARMACEUTICALS, INC., Yunnan (CN)
Filed by KPC PHARMACEUTICALS, INC., Yunnan (CN)
Filed on Dec. 29, 2020, as Appl. No. 17/136,282.
Claims priority of application No. 201911391840.4 (CN), filed on Dec. 30, 2019.
Prior Publication US 2021/0196736 A1, Jul. 1, 2021
Int. Cl. A61K 31/7034 (2006.01); A61P 11/14 (2006.01)

CPC A61K 31/7034 (2013.01) [A61P 11/14 (2018.01)]

5 Claims

1. A method of treating a disease of respiratory system with a cough symptom, comprising administering trezastilbenoside to a subject in need thereof, wherein the cough symptom is induced by inhalation.